A Review of a Traditional Chinese Medicine Formula for Treating Insomnia with Depression: Wendan Decoction

被引:0
作者
Kong, Lingyuan [1 ]
He, Xinyi [1 ]
Li, Xiuyang [1 ]
机构
[1] Shandong Univ Tradit Chinese Med, Jinan 250355, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
Traditional Chinese medicine; insomnia with depression; Wendan Decoction; clinical research; pharmacology; GLYCYRRHIZA-URALENSIS; STRESS; LIQUIRITIGENIN; BEHAVIOR; EXTRACT; ACID; MICE;
D O I
10.1177/09731296241246313
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: The relationship between insomnia and depression is complex and two-way. Long-term insomnia may cause, maintain, and aggravate depression, and with the development of the disease, depression patients will also experience insomnia symptoms. Oral medication is currently the main treatment for insomnia with depression (ID). Drugs such as Estazolam have good anti-anxiety and insomnia effects, high safety, and relatively small side effects. They are widely used in the treatment of ID in clinics, but some patients still have adverse reactions or low efficacy when taking Estazolam and other drugs. In recent years, Chinese herbal medicine and TCM prescriptions for the treatment of mental illness have been more and more accepted and studied by international scholars. The efficacy of Wendan Decoction (WDD) has been tested by ancient China for nearly 1,400 years, and with the development of modern pharmacological research, it is widely used in the treatment of insomnia and depression.Purpose: Therefore, based on the understanding of ID in TCM, this article discusses the pharmacodynamic effect of WDD, and based on existing clinical and experimental studies, comprehensively analyzes the clinical observation, mechanism of action, and pharmacological effect of WDD in the treatment of ID, to provide more clinical experience and experimental theoretical support for WDD in the treatment of ID.Methods: Retrieve Chinese and English literature on the treatment of ID with WDD from databases such as Web of Science, etc.Conclusion: WDD has good therapeutic effects on ID.
引用
收藏
页码:348 / 363
页数:16
相关论文
共 101 条
[1]   Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research [J].
Ali, Badreldin H. ;
Blunden, Gerald ;
Tanira, Musbah O. ;
Nemmar, Abderrahim .
FOOD AND CHEMICAL TOXICOLOGY, 2008, 46 (02) :409-420
[2]   A CHANGE OF MIND [J].
Anthes, Emily .
NATURE, 2014, 515 (7526) :185-187
[3]   A comprehensive review on ethnopharmacological, phytochemical, pharmacological and toxicological evaluation, and quality control of Pinellia ternata (Thunb.) Breit. [J].
Bai, Jing ;
Qi, Jianbo ;
Yang, Li ;
Wang, Zhengtao ;
Wang, Rui ;
Shi, Yanhong .
JOURNAL OF ETHNOPHARMACOLOGY, 2022, 298
[4]   Licochalcone F alleviates glucose tolerance and chronic inflammation in diet-induced obese mice through Akt and p38 MAPK [J].
Bak, Eun-Jung ;
Choi, Kyung-Chul ;
Jang, Sungil ;
Woo, Gye-Hyeong ;
Yoon, Ho-Geun ;
Na, Younghwa ;
Yoo, Yun-Jung ;
Lee, Youngseok ;
Jeong, Yangsik ;
Cha, Jeong-Heon .
CLINICAL NUTRITION, 2016, 35 (02) :414-421
[5]   The Bidirectional Relationship of Depression and Inflammation: Double Trouble [J].
Beurel, Eleonore ;
Toups, Marisa ;
Nemeroff, Charles B. .
NEURON, 2020, 107 (02) :234-256
[6]  
Cai Z. G., 2021, WORLD J SLEEP MED, V8, P57, DOI [10.3969/j.issn.2095-7130.2021.01.021, DOI 10.3969/J.ISSN.2095-7130.2021.01.021]
[7]   Licochalcone B, a chalcone derivative from Glycyrrhiza inflata, as a multifunctional agent for the treatment of Alzheimer's disease [J].
Cao, Yingying ;
Xu, Wenxing ;
Huang, Yiyou ;
Zeng, Xing .
NATURAL PRODUCT RESEARCH, 2020, 34 (05) :736-739
[8]   Chronic unpredictable stress impairs endogenous antioxidant defense in rat brain [J].
Che, Yi ;
Zhou, Zhu ;
Shu, Yuxin ;
Zhai, Chao ;
Zhu, Yuanyuan ;
Gong, Songjie ;
Cui, Yonghua ;
Wang, Jun-Feng .
NEUROSCIENCE LETTERS, 2015, 584 :208-213
[9]  
Chen J., 2010, J FUJIAN U TRADITION, V20, P10, DOI [10.13261/j.cnki.jfutcm.002392, DOI 10.13261/J.CNKI.JFUTCM.002392]
[10]  
Chen S. Q., 2022, DRUG EVALUATION, V19, P887, DOI [10.19939/j.cnki.1672-2809.2022.14.15, DOI 10.19939/J.CNKI.1672-2809.2022.14.15]